Management of variceal bleeding: PSG guidelines 2006

Journal of the Pakistan Medical Association

Volumn 57, Issue 10, 2007, Pages 505-511

  Farooqi, Javed Iqbal ^a   Jafri, S M Wasim ^a   Najib ul Haq, ^a   Niaz, Saad Khalid ^a   Hamid, Saeed ^a   Abbas, Zaigham ^a   Tayyab, Ghias Un Nabi ^a   Nawaz, Arif Amir ^a   Umar, Muhammad ^a   Memon, Jan Muhammad ^a  

^a Moderators and Panelists of PSG Consensus Meeting ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENBUCRILATE; ISOSORBIDE MONONITRATE; LACTULOSE; NADOLOL; NITRATE; OCTREOTIDE; PROPRANOLOL; PROTON PUMP INHIBITOR; SOMATOSTATIN; TERLIPRESSIN;

ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMAN; LIVER CIRRHOSIS; LIVER GRAFT; PRACTICE GUIDELINE; REVIEW; STOMACH VARICES; ACUTE DISEASE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; PAKISTAN; PORTAL HYPERTENSION; RISK FACTOR;

ACUTE DISEASE; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PAKISTAN; RISK FACTORS;

EID: 38449115823     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. No authors listed. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 1988; 319: 983-9.
2. Groszmann RJ, Bosch J, Grace ND, Conn HO, Gracia- Tsao G, Navasa M, Alberts J. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99: 1401-7.
3. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989; 96: 1552-9.
4. Gralnek IM, Jensen DM, Kovacs TO, Jutabha R, Machicado GA, Gornbein J, King J. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endosocpic therapy. Hepatology 1999; 29: 44-50.
5. Burroughs AK, McCormick PA. Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 1992; 6: 437-50.
6. Cello JP, Grendell JH, Crass RA, Weber TE, Trunkey DD. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. N Engl J Med 1987; 316: 11-5.
7. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-9.
8. Koransky JR, Galambos JT, Hersh T, Warren WD. The mortality of bleeding esophageal varices in a private university hospital. Am J surg 1978; 136: 339-41.
9. Jalan R, Hayes PC. UK guidelines on the management of variceal hemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000; 46 Suppl 3: iii1-iii15 (June)
10. Renner E. OMGE Practice Guideline: Treatment of Esophageal Varices. May 2003. http://www.omge.org/guidelines/guide08/g_data8_en.htm.
11. de Franchis R. Evolving Consensus in Portal Hypertension. Report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. J Hepatology 2005; 43: 167-76
12. Eccles M, Clapp Z, Grimshaw J, Ad́ams PC, Higgins B, Purves I, Russell I. North of England evidence based guidelines development project: methods of guideline development. BMJ 1996; 312: 760-2
13. Eccles M, Rousseau N, Freemantle N. Updating evidence-based clinical guidelines. J Health Serv Res Policy. 2002 ;7: 98-103.
14. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995; 274:1800-4
15. Eccles M, Mason J. How to develop cost-conscious guidelines. Health Technol Assess. 2001; 5:1-69.
16. Eccles M, Mason J, Freemantle N. Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project. Qual Health Care. 2000; 9:127-32.
17. No authors listed. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. The Veterans affairs Cooperative Variceal Sclerotherapy Group. N Eng J Med 1991; 324: 1779-84.
18. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19: 475-505.
19. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999; 94: 3285-91.
20. Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001; 33:333-8.
21. Albillos A, Lledo JL, Rossi I, Perez-Paramo M, Tabuenca MJ, Banares R et al. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function. Gastroenterology 1995; 109: 1257-65.
22. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-9.
23. Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology 1982; 82: 968-73.
24. No authors listed. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. The Copenhagen Esophageal Varices Sclerotherapy Project. N Engl J Med 1984; 311: 1594-600.
25. de Franchis R, Primignani M. Why do varices bleed? Gastroenterol Clin North Am 1992; 21: 85-101.
26. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139-44.
27. Vinel JP, Cassigneul J, Levade M, Voigt JJ, Pascal JP. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology 1986; 6: 116-7.
28. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long term follow-up study in 568 porta! hypertension patients. Hepatology 1992;16:1343-9.
29. Huang YH, Yeh HZ, Chen GH, Chang CS, Wu CY, Poon SK, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2- cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000;52:160-7.
30. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001;33:1060-4.
31. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002;97:1010-15.
32. Teres J, Cecilia A, Bordas JM, Rimola A, Bru C, Rodes J. Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 1978;75:566-9.
33. Panes J, Teres J, Bosch J, Rodes J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988;33:454-9.
34. Barange K, Peron JM, Imani K, Otal P, Payen JL, Rousseau H, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999;30:1139-43.
35. Azoulay D, Castaing D, Majno P, Saliba F, Ichai P, Smail A, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001;35:590-7.
36. Patch D, Nikolopoulou V, McCormick A, Dick R, Armonis A, Wannamethee G, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998;28:454-60.